Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series
1. Harmony Biosciences will participate in H.C. Wainwright series on July 17, 2025. 2. The event showcases company commitment to rare neurological disease therapies. 3. Webcast availability increases transparency and investor engagement.